This inventor holds 4 USPTO granted patents. Top assignee: University of Oklahoma. Active years: 2010-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2019
Title: Innovations by Bengt G S Linderoth
Introduction
Bengt G S Linderoth is a notable inventor based in Solna, Sweden. He has made significant contributions to the field of cardiac neuromodulation, holding a total of four patents. His work focuses on innovative methods for treating heart failure and improving cardiac function.
Latest Patents
Linderoth's latest patents include groundbreaking methodologies for cardiac neuromodulation. One patent describes a method of treating heart failure by implanting a stimulation device that electrically stimulates the spinal cord. This device is activated to deliver electrical stimulation, which can significantly improve patient outcomes. Another patent relates to methodologies for quenching preconditioning and enhancing communication between the intrinsic cardiac nervous system and electrical stimuli. This invention utilizes spinal cord stimulation to protect myocytes, stabilize myocardial electrical instability, and alleviate various cardiac pathologies.
Career Highlights
Bengt G S Linderoth has established a prominent career in the field of cardiac research. He is affiliated with the University of Oklahoma, where he continues to advance his research and innovations. His work has garnered attention for its potential to transform treatment approaches for heart-related conditions.
Collaborations
Linderoth has collaborated with esteemed colleagues, including Robert D Foreman and Jeffrey L Ardell. These partnerships have contributed to the development of his innovative patents and research initiatives.
Conclusion
Bengt G S Linderoth is a pioneering inventor whose work in cardiac neuromodulation has the potential to significantly impact the treatment of heart failure. His innovative patents reflect a commitment to advancing medical technology and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
